Clawback tax reaches unsustainable level for generic drugs, warns APMGR

Georgiana Bendre 03/05/2017 | 16:00

The clawback tax went up again in the first quarter of this year to an unsustainable level for generic drugs, says the Association of Generic Medical Drugs from Romania (APMGR), asking for a differentiated clawback tax for generic drugs.

The “p” percentage from the clawback tax computation increased in the first quarter to 19.86 percent compared with 15.62 percent in the first quarter of 2016. APMGR says that there is no other measure that can be implemented immediately, without costs for the state budget, that could block the disappearance of drugs with reduced price of the market and closing the entire production line of the factories of local drugs.

“The level of this tax is not sustainable for generic drugs. The ones who will suffer are especially the seniors and the chronic diseased, who won’t find many of the wide-spread drugs on the market and we’ll find more expensive alternatives, that will require payment aid,” said Laurentiu Mihai, executive director of APMGR.

“We discuss different solutions with the other producers, with the representatives of the Health Ministry and the Finance Ministry, with the Health Insurances National Agency, but until the identification of an ideal mechanism, we asked for the introduction of a differentiated computation until January 1 2019,” added Mihai.

The draft bill for the differentiated computation of the clawback tax for generic drugs was approved by the Senate in September 2014 and it is debated in the Deputies Chamber.

BR Magazine | Latest Issue

Download PDF or read online: July 2023 Issue | Business Review Magazine

The July 2023 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “At a Crossroads: Budget Deficit Endangering Romania’s Economic
Georgiana Bendre | 31/07/2023 | 14:14

    You will receive a download link for the latest issue of Business Review Magazine in PDF format, based on the completion of the form below.

    I agree with the Privacy policy of

    I agree with the storage and handling of my data by

    Advertisement Advertisement
    Close ×

    We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

    Accept & continue